Increasing Cases of Obesity and Hypertension to Drive Demand for Atrial Fibrillation Treatment

Irregular heartbeat leading to blood clots and heart failure is termed as atrial fibrillation. The growing geriatric population worldwide and increase in obesity and hypertension cases are expected to boost the demand for atrial fibrillation treatment. Companies venturing in the atrial fibrillation treatment space are coming up with effective techniques to curb the risk of heart attacks caused by atrial fibrillation. 

According to a report published by Transparency Market Research, the global atrial fibrillation market is expected to rise at a 13.4% CAGR between 2013 and 2019 to touch a valuation of US$14.8 bn in 2019.

Research Report: 

http://www.transparencymarketresearch.com/atrial-fibrillation-market.html

What factors are responsible for driving the global demand for atrial fibrillation treatment?

The increase in the global geriatric population is one of the major reasons for the increasing cases of atrial fibrillation. With old age, the risk of heart diseases, obesity, and hypertension heightens, leading to a greater risk of heart failure. Disorders such as obesity and hypertension are also prevalent among the young population, thus leading to atrial fibrillation and the need to curb it. Many companies are investing in clinical trials targeted towards curing atrial fibrillation and have also exhibited favorable results so far. 

For instance, The Heart Institute of Florida at the Florida Medical Center recently announced a new procedure to treat Caribbean atrial fibrillation patients using the convergent approach. The process helps restore the normal heart rhythm for patients who have been suffering from atrial fibrillation for a long time. 

How will the implementation of strict regulations regarding product approval affect the adoption of atrial fibrillation treatments? 

Patients suffering from atrial fibrillation frequently intake drugs with non-pharmacological treatments to reduce the risk of stroke before going through an electric cardioversion. Thus, to avoid complications, these drugs have to go through rigorous tests to get their approval from the FDA, CE, and other medical agencies. The European Medicine Agency has the strictest regulations regarding the approval of atrial fibrillation drugs. The delay in the approval process and rejections due to strict guidelines is likely to hamper the market growth of atrial fibrillation treatment. 

In spite of these drawbacks, analysts predict that pharmacological treatments are expected to dominate the global atrial fibrillation treatment market with a share of 55% by the end of 2019. The launch of advanced drugs is also likely to boost the demand for atrial fibrillation treatment. According to the TMR report, Asia Pacific, North America, and Europe along with the Rest of the World are the main regions for the market of atrial fibrillation. Among these, North America is expected to maintain its dominance until 2019 followed by Europe and Asia Pacific. Asia Pacific is projected to witness the highest growth by 2019. Some of the leading companies in the global atrial fibrillation market are Boehringer Ingelheim GmbH, Boston Scientific Corp., CardioFocus Inc., AtriCure Inc., Endoscopic Technologies Inc., Biosense Webster Inc., Sanofi Aventis, St. Jude Medical Inc., Bristol-Myers Squibb Corp., and Johnson and Johnson Ltd.

Demand for Knee Cartilage Repair to Increase Due to Increasing Incidence of Bone and Joint Disorders

Knee cartilage repair is used to treat damaged articular cartilages that cause pain by restricting normal knee movement. For severe conditions such as delayed unions, mal-unions, and wounds that heal slowly, knee cartilage repair is substantially beneficial. The advances made in the products for knee cartilage repair have propelled its industry growth and is further expected to boost the demand for knee cartilage repair. 

According to Transparency Market Research, the global knee cartilage repair market is projected to expand at a CAGR of 5.8% between 2015 and 2023. The market value is expected to rise from US$1.6 bn in 2014 to US$2.7 bn in 2023.

How effective will the rise in global geriatric population be in increasing the demand for knee cartilage repair?

Aged people are more prone to bone problems. Among the most common orthopedic disorders they could face, knee cartilage damage is the most prevalent problem. The wear and tear of knee cartilages are the most troubling injuries to manage in old age. The growing geriatric population is expected to bolster the demand for knee cartilage repair due to the support they provide to frail knee joints. The awareness among people regarding the benefits of knee cartilage repair is expected to fuel the demand for knee cartilage repair in future. The obese and elderly population is often exposed to degenerative diseases such as rheumatoid arthritis, osteoarthritis, and several other trauma wounds. Thus, these factors are likely to boost the demand for knee cartilage repair among elderlies as they focus on the stability and repair of their knee joints.

What opportunities can market players gain from emerging economies?

The knee cartilage repair market is rising at a momentous pace in the developing regions due to the mounting cases of obesity and knee cartilage injuries among the geriatric population in these regions. The growth of medical tourism in Asia is expected to further fuel demand for the products of knee cartilage repair. The emergence of new procedures pertaining to knee cartilage repair in the emerging economies is one of the substantial opportunities that vendors of knee cartilage repair can look forward to. Moreover, due to the rising number of sport injuries, the demand for knee cartilage repair is likely to rise. 

The most popular among all the procedures adapted in the repair of knee cartilage is anthroscopic chondroplasty as it takes less time recover compared to the generic procedures of knee surgery. It is estimated to maintain its dominance till 2023. 

In spite of the various growth opportunities that the emerging countries are likely to provide to the leading vendors in the market, poor reimbursement policies and the lack of efficient health insurance schemes can hamper growth of the knee cartilage repair market in the future. 

Browse Research Press Release:

http://www.transparencymarketresearch.com/pressrelease/knee-cartilage-repair-market.htm

The global knee cartilage market was dominated by North America in 2014. The region is expected to maintain its dominance till 2023 due to the implementation of favorable reimbursement policies such as the Affordable Care Act. However, Asia Pacific is projected to be the market exhibiting the highest growth opportunities to the market due to significant economic growth in the region. Leading companies such as Zimmer Biomet, B. Braun Melsungen, DePuy Synthees, Stryker Corporation and Smith & Nephew plc are focusing on mergers and acquisitions to sustain their position in the extremely competitive market. 

Rising Incidence of Skin Disorders Translates into Greater Uptake of Skincare Devices

The need for efficient devices to diagnose and treat various skin-related conditions, such as skin cancer and dermatological indications, has resulted in being a great opportunity for the global skin devices market. The consumption of skin care devices has significantly increased in response to increased cases of skin cancer. Moreover, these devices deliver the majority of customers with the opportunity to benefit from positive beauty outcomes.

According to a study by Transparency Market Research (TMR), the global skincare devices market is anticipated to grow at a CAGR of 10.1% between 2015 and 2023. TMR has predicted the market to reach a valuation of US$17.30 bn by 2023, from US$7,255.8 bn in 2014.

How is the growing emphasis on aesthetics complementing the global skincare devices industry?

The rising preference for beauty procedures and the desire to improve physical beauty have encouraged consumers to spend on skincare devices. Additionally, people suffering from simple skin-related problems such as wrinkles, pimples, freckles, fine lines of aging, and unwanted hair are looking for pain-free and fast solutions. All these factors can potentially bolster the growth of the global skincare devices market. 

Moreover, newer technologies are helping in the development of skincare devices in response to the growing demands of costumers. The introduction of smart and portable devices has proven to be favorable to the growth of the global skincare devices market.

How are developing nations helping boost the sales of skincare devices globally?

With the rising popularity of substitutes such as light therapy and liposuction, the popularity of skincare devices is likely to register a downfall in the coming years. Also, the growing usage of cosmeceuticals such as Botox and dermal fillers will also impede the growth of the market globally.

However, according to TMR analysts, the untapped opportunities in the developing countries of Asia Pacific are likely to make them a lucrative market. The propitious growth in the skincare devices market of the region can be attributed largely to the presence of a large population with high demand for beauty and wellness. Furthermore, a rise in the number of med spas and medical tourism will reflect positively on sales prospects for skincare devices.

How are various environmental and lifestyle factors contributing to increased sales of skincare devices?

Based on application, cellulite reduction forms the leading segment. Cellulite is a state of continuous fat deposition causing skin dimpling. The TMR study reports that nearly 85% to 98% women across the globe are affected by cellulite. The increasing incidence of cellulite is likely to give a great push to the skincare devices market.

Other than cellulite, the growing cases of skin disorders such as skin cancer are anticipated to propel the demand for skincare devices. The rising demand for skincare devices such as dermatoscopes, biopsy devices, and image guidance systems and treatment techniques such as lasabrasion and light therapy will boost the growth of the skincare devices market globally.

Browse Industry Press Release:

http://www.transparencymarketresearch.com/pressrelease/skincare-devices-market.htm

According to the Skin Care Foundation, one in five Americans can develop skin cancer in the course of a lifetime. The high rate of skin cancer in North America makes it a lucrative market for skincare devices. Moreover, the high demand for non-invasive aesthetic procedures from the region has made it the leading segment in terms of geography. 

Increasing Cases of Cardiovascular Diseases Surge the Demand for Cardiac Rehabilitation Devices Globally

Cardiac rehabilitation (rehab) is a professionally administered program that works on improving the health of people who have heart problems. Cardiac rehab devices are gaining prominence as they help in increasing physical fitness, reducing cardiac symptoms and make it easier for patients to return to an active life. With a rising global population crossing the age of 60, the risk of cardiovascular diseases is also increasing.

Rapidly increasing geriatric population and growing concerns for cardiovascular diseases are the key factors driving the growing demand for effective cardiac rehabilitation devices worldwide. A Transparency Market Research (TMR) study estimates the growth of the global cardiac rehabilitation market at a CAGR of 5.4% from 2016 to 2024. The valuation of the global market will rise to US$1.62 bn by 2024; it was US$1.01 bn in 2015. 

How are technological advancements helping cardiac rehabilitation gain prominence?

The cardiac rehabilitation devices market is highly research-intensive and thus, new technologies move in periodically. By device type, the global cardiac rehabilitation market is segmented into seated and upright elliptical trainer, blood pressure monitor, stabilization ball, heart rate monitor, stationary bicycle, rower, and treadmill. The elliptical trainer segment is anticipated to lead from 2016 through 2024, accounting for an approximately 27% share of the global market in 2015. Research carried out by the National Center for Biotechnology Information (NCBI) finds that elliptical trainers are more beneficial than exercises such as cycling, ground walking, and treadmill walking.

The heart rate monitors segment is also anticipated to report steady growth in the global cardiac rehabilitation market in the coming years. Increasingly reliable outputs of new-age products, technological advancements, and their portable nature are the factors that will give a great push to the sales of heart rate monitors globally.

How conducive is the cardiac rehabilitation devices market for vendors?

The global cardiac rehabilitation market is a capital-intensive market where the risk of being transcended by the advent of newer technologies is immense. Another concern is that the enrolments in cardiac rehabilitation programs are low; this situation is compounded by the shortage of appropriate resources. 

However, governments and various educational institutes have started encouraging cardiac rehabilitation programs, giving a boost to the number of rehabilitation counselors across the globe. This will consequently stimulate sales of cardiac rehabilitation products. Furthermore, newer technologies are also helping in cutting down costs.

How are developing countries benefitting the global cardiac rehabilitation market?

Cardiovascular diseases are already a huge problem that beset the developing and underdeveloped nations such as countries in Asia Pacific, Africa, and Latin America. 37% of the total deaths in these regions are due to cardiovascular diseases. As a result, efforts are being undertaken to spread awareness about the cardiac rehabilitation practices and devices. 

Browse Research Press Release:

http://www.transparencymarketresearch.com/pressrelease/cardiac-rehabilitation-market.htm

Unhealthy lifestyles including detrimental food habits are also leading to an increased number of cardiovascular diseases. High cholesterol levels among the population of North America due to unhealthy food habits has fueled the growth of cardiac rehabilitation market in the region. As a result, North America leads with over 50% of the global market and is anticipated to retain its leadership throughout the forecast period.

Government Efforts Crucial in Increasing the Availability of Teleradiology Technology in Asia Pacific

Teleradiology is a crucial component of modern healthcare and comprises of various technologies used to allow easy sharing of diagnostic information within the medical community. While radiology itself has been a major part of healthcare for over a century, the recent advancement in digital information broadcasting technologies has allowed for the steady emergence of teleradiology. The ease of sharing diagnostic images with modern communication technologies has resulted in increasing collaboration to make the diagnostic procedure more accurate.

According to Transparency Market Research, the global teleradiology technology market was valued at more than US$1.3 bn in 2014. Exhibiting a robust 11.30% CAGR from 2015 to 2023, the market’s valuation is expected to rise to US$3.6 bn. Cloud-based teleradiology is likely to become a major part of the global teleradiology technology market in the coming years.

What are the major drivers for the global teleradiology technology market?

The prime factors driving the demand for teleradiology technology are the increasing healthcare expenditure among urban consumers and the rapid technological advancement in communication infrastructure, which has allowed hospitals all over the world to install teleradiology technology with relative ease. The steady expansion of telecommunications technologies in rural areas has also helped the global teleradiology technology market gain widespread demand. The high costs of radiology are also steadily being offset by the increasing disposable income of urban consumers. 

Which is the major regional market for teleradiology technology?

Despite North America’s dominance in the global teleradiology technology market, which is a result of the constant innovation of advanced technology in the region, Asia Pacific is likely to be the most influential regional segment of the global market in the coming years. The rapid urbanization in Asia Pacific has allowed medical care providers to include teleradiology services, while the increasing presence of telecommunications technology in rural areas is allowing small-scale healthcare providers to collaborate with major hospitals in order to improve their radiological diagnostics.

Last month, the Indian state of Uttarakhand was declared to be in line for installation of teleradiology technology at state-run hospitals, indicating the promising prospects for the teleradiology technology market in Asia Pacific. Despite the presence of radiology equipment, the lack of competent diagnosticians is often the complaint in relatively undeveloped areas. This move will allow the local hospitals to collaborate with private radiologists, who can provide their diagnoses remotely. Such schemes are being implemented across Asia Pacific, thanks to their convenience for both parties. China and Japan are also likely to be dominant in the Asia Pacific market for teleradiology technology. 

For Technical Insights Visit:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1132

Teleradiology technology is also likely to benefit from the increasing efforts in developed regions such as North America and Western Europe to have different medical teams coordinating for obtaining diagnoses. This increases the chances of obtaining the correct diagnosis and thus aids patient outcomes. 

High Incidences of Hearing Losses Induces High Demand for Hearing Aids

Hearing aids are devices that provide assistance to the partially deaf people by amplifying the sound signals. The hearing aids market is anticipated to boom owing to the increasing number of hearing impairment cases. However, a report by WHO indicates that the hearing aid production globally could hardly meet 10% of the total need in 2015.

Growing Geriatric Population Fuels the Demand for Hearing Aids: With a rising global population crossing the age of 60, the risk of hearing impairment is also increasing. The sales of hearing aids are positively influenced by the increasing geriatric population across the globe. Moreover, features such as proper insulation and easy-fit on the ear make hearing aid a popular choice amongst the old-age population.

Government initiatives Back the Growth of Hearing Aids Market: An increase in the level of awareness in the patients regarding the hearing aids in the last few years can be attributed to government campaigns and incentives aimed at curbing the incidence of hearing loss. The technological advancements are also playing a significant role in augmenting the sales of hearing aids. The introduction of rechargeable hearing aids with quick charging features and long lasting battery life will bolster the growth of the market. 

High Prevalence of Hearing Impairment among Adults Open Avenues for Research: Various studies report that nearly 6% of the global population suffers from hearing loss, out of which approximately 95% are adults. The incidences of hearing impairment are increasing at an alarming rate. This opens avenues for development of new products.

Research Report: http://www.transparencymarketresearch.com/hearing-aid-market.html

Opportunities for the growth of the market are most conducive in Europe and has registered the highest number of users of hearing aids. However, rising investment in the healthcare infrastructure and high unmet medical needs are likely to make Asia Pacific market lucrative.

Emergence of Home-based Healthcare to Shape Utilization of Mobile Imaging Services

Mobile imaging services comprise a group of devices and technologies that allow diagnostic imaging to be conducted in non-hospital settings and the results sent to physicians. This is especially convenient in situations where the patient is suffering from disorders that restrain their movement, or the patient is in a remote area and can’t physically visit the hospital. The growing demand for home healthcare solutions is thus favorable for the mobile imaging services market. Hospitals themselves are also exhibiting increasing demand for mobile imaging services, as they present a cost-effective alternative over conventional fixed medical imaging equipment.

According to Transparency Market Research, the global mobile imaging services market was valued at US$10.7 bn in 2013. Exhibiting a steady 3.2% CAGR from 2014 to 2020, the market is expected to rise to a valuation of US$13.3 bn.

How important will hospitals be to the mobile imaging services market in the coming years?

Despite their obvious utility in healthcare dispensation to remote areas or in home-based healthcare settings, the primary driver for the demand for mobile imaging services is their increasing use in hospitals. While stationary imaging equipment has been the norm in hospitals for a long time, the impending obsolescence of many imaging devices in the face of consistent technological advancement has necessitated the use of cost-effective modern alternatives such as mobile imaging.

Small hospitals are the key end users of mobile imaging services. These hospitals need to keep in touch with the contemporaneous technological scenario, but the relatively low volume of patients doesn’t allow them to install advanced stationary equipment on a mass scale. In this situation, using outsourced mobile imaging services becomes a vital solution for hospitals operating in a certain budget range. This is the way the mobile imaging services market has shaped up in North America and Europe. The increasing sophistication of teleradiology technologies is likely to ensure it remains this way in the coming years.

Browse Research Release: 

http://www.transparencymarketresearch.com/pressrelease/global-mobile-imaging-services.htm

What is the key trend in the global mobile imaging services market?

The launch of mobile imaging units by major hospitals is a key trend in the global mobile imaging services market. While it has increased the demand for mobile imaging equipment, the high transportation costs and frequent maintenance requirements may put many hospitals off the idea of establishing their own mobile imaging unit. The increasing ease of incorporating teleradiology solutions is also likely to count against the mobile imaging services market, especially with smaller hospitals.

The increasing global geriatric population has led to the development of imaging solutions that don’t require the patients to be physically present in the hospital, and home care solutions are already becoming common in North America and Western Europe, which are virtually the only markets for mobile imaging services at present. This is another key driver for the global mobile imaging services market.

Demand for Acute Care Needleless Connectors to Grow due to Official Recognition of Safety Benefits

Acute care needless connectors have become an integral part of healthcare following a steady growth curve since their early development in the 1980s. Needleless connectors have replaced needle-based catheters, syringes, and administration sets in developed regions due to the increasing awareness about the risk of needlestick injuries. Acute care, which usually contains a hematological component to diagnose or monitor the condition, is thus becoming a major application area for needless connectors.

According to Transparency Market Research, the global market for acute care needleless connectors is expected to exhibit a sturdy 10.20% CAGR between 2014 and 2020, with the market’s valuation rising to US$972 mn by the end of the forecast period. The increasing uptake of needless connectors in acute care settings to reduce the prevalence of needlestick injuries to hospital staff as well as patients is the prime driver for the global market.

What is the position of global healthcare bodies on the use of acute care needleless connectors?

According to the Centers for Disease Control and Prevention, more than 300,000 sharps-related (including needlesticks as well as scalpels and other sharp instruments) injuries occur among healthcare workers in the U.S. every year. While the number of sharps injuries fell by 31.6% over the 2001-2006 period for nonsurgical settings, the number of injuries in surgical settings increased by 6.5%. Acute care needlestick connectors, which are mostly used in nonsurgical settings such as diagnosis or monitoring, have thus been shown to be a contributing factor to a reduction in the decrease in sharps injuries.

Meanwhile, according to the WHO, more than 30% of healthcare workers suffering from hepatitis B or C contract the disease from a needlestick injury. While the number is much lower for HIV/AIDS contamination – around 4% – it still is a significant concern, considering the dire prognosis of the disease. As a result, the WHO also supports initiatives to increase the use of needless connectors.

What are the major restraints on the acute care needleless connectors market?

The high risk of catheter-related bloodstream infections following the use of needleless catheters is a major restraint on the global demand for acute care needleless connectors. Since this negates the purpose of installing catheter systems that are safer than the conventional options, the acute care needleless connectors industry has taken this issue seriously, and several research projects are underway to develop needleless catheters that do not cause infections.

The large number of players operating in the global acute care needleless connectors market also means there is a significant price difference between branded and generic products. This is another key restraint on the organized acute care needleless connectors market, as branded products often require a prohibitively high investment.

Interpret a Competitive outlook Analysis Report with free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4230

On the other hand, the increasing demand for advanced healthcare solutions in emerging Asia Pacific, Middle Eastern, and Latin American economies is the key opportunity for manufacturers of acute care needleless connectors.

Trend of Miniaturization to Propel Global Demand for Microscopy Devices

Nanotechnology, which has applications in semiconductors, life sciences, and material sciences, requires high-resolution microscopes for the study of materials at an atomic or molecular level. Microscopes are also a critical requirement in manufacturing industries demanding precision. Initiatives by various governments aimed towards increasing the R&D funding in the healthcare sector are also triggering the demand for microscopy devices. Thus, the global microscopy devices market is expected to rise from US$5.7 bn in 2013 to US$9.7 bn by 2020 expanding at a 7.60% CAGR from 2014 to 2020.

TMR analysts answer key questions that companies operating in the microscopy devices market need to ask:

Q. What are the growth opportunities in the microscopy devices market?

Of late, the trend of miniaturization has taken the world by storm. This trend offers a great opportunity for advanced microscopy devices such as transmission electron microscopes (TEM), scanning electron microscopes (SEM), and scanning probe microscopes (SPM). The semiconductor industry is moving towards miniaturization of transistor chips. Companies such as Samsung and United Microelectronics are anticipated to roll out ultra-nano chips soon. Thus, this trend is expected to generate new demand for advanced microscopy devices. 

The entry of quantum dots (QD) technology in the semiconductor industry will also benefit the microscopy devices market by opening another door of opportunity for growth. QD technology has already been used in the Bravia television series by Sony. The QD technology, which is currently at its nascent stage, is expected to be commercialized in the future and will bring huge opportunities of growth for the SPM and electron microscope types.  

Q. What is restricting the growth of the global microscopy devices market?

The complex instrumentation of advanced microscopes is one of the challenges faced by the market. The special, intricate sample preparation techniques required by these microscopy devices also pose a challenge. This is because the samples, when viewed under these microscopes, are altered structurally or even destroyed. This restricts the use of microscopy devices in many potential fields. 

Scanning probe microscopes have glitches such as inability to examine the buried interfaces between two media, low scanning rate, and smaller image size. 

The premium pricing of advanced microscopy devices also limits the penetration of these devices. Several private research institutes and small companies need high-end microscopy devices but are unable to purchase them since they cannot afford them. Insufficient funding is also restricting the purchase of these devices by many research institutes that are dependent on federal and corporate funding. 

For More Technical Insights Visit: 

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=226

Q. What are the recent developments in microscopy devices by key players?

Carl Zeiss, a company based in Germany has introduced a new hardware auto focus and clean room kit for the Axio Imager microscope system. FEI Company, headquartered in Oregon, has announced the new ASPEX CleanCHK analyzer that offers a particulate contamination monitor, and is explicitly designed for application in the automotive industry. Hitachi High-Technologies has introduced the new generation TEM that functions even in room light environments. 

Such new developments and, most importantly, the growing use of microscopy devices in various fields will bring about healthy growth in the market. 

Ability to Transform Lives Gives Advanced Patient Monitoring Systems a Fresh Boost Globally

The future of healthcare has been changing with every move that technology makes. From improvements in diagnostic machines to taking medical practitioners right to the doorstep of the patient, the joint ventures of technology and healthcare have solved innumerable problems over the past few years. 

The increasing pool of geriatrics, developments in wireless technologies, and the rise of enhanced telecom services have all been at the helm changing the quality of medical care and disease management. A new research report by Transparency Market Research shows that advances in remote patient monitoring systems are poised to revolutionize the game by reducing operating costs and closely tracking patient’s health. From monitoring chronic conditions to helping patients manage diseases that impact a normal life such as diabetes, this branch of technology is truly proving its mettle.

Q. How have advanced remote patient monitoring systems changed healthcare?

A. The proliferating nature of healthcare business has encouraged the rise technological solutions that connect patients and physicians, despite the challenges of distances. These technologies are being designed to learn worrying signs and notify the patient before the condition turns into a threat. Some of the sleep disorder diagnostics solutions by CleveMed are helping patients to overcome sleep apnea. Its products such as SleepViewSM Web-portal, Sapphire PSG™, SleepView®, SleepScout™, and SleepView Direct are aimed towards normalizing sleep patterns and improving the rate of diagnostics and treatment. These devices secure patient-related information, store it on the cloud, and use it for deducing a logical conclusion. The AliveCor® Heart Monitor also works on a similar principle. This device works in conjunction with the user’s smartphone to record an accurate ECG. Additionally, it also monitors effects of medicines, changing symptoms, and palpitations to determine the health of the patient.

Q. What are the benefits of remote patient monitoring systems?

A. The obvious benefits of remote patient monitoring systems are improved quality of lives, real-time support from medical practitioners in the case of emergencies such as asthma attacks or heart failures, and availability of home case post discharge. 

The aforementioned advantages have also brought down the number of readmissions for patients, thereby eliminating chances of prolonged hospital stays and recurring costs. On the other hand, advanced remote patient monitoring systems also bring in clarity in more accountability, compliance, and reduced the cost of care thereby making insurance companies happy.

Q. How will remote patient monitoring systems reduce economic burden?

A. Statistics show that a rise in the number of geriatrics and rising cases of chronic obstructive pulmonary disease (COPD) are straining the healthcare systems. Furthermore, the high incidence of diabetes, cardiac arrhythmia, ischemic diseases, hypertension, sleep apnea, and hyperlipidemia are also adding to the insurmountable medical expenses that cannot be afforded by many. 

As the number of geriatrics are expected to reach 265 million by 2020, deployment of patient monitoring systems will help to deliver value-for-money services. This will also allow the elderly patients to remain independent, thereby reducing the economic burden on themselves, primary caregivers, and the hospitals. 

Download Brochure for Technical Insights:

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3444

However, the biggest drawback of advanced remote patient monitoring systems is the possibility of technical glitches that can render the systems useless. Furthermore, methods of tracking consultations with patients for remunerating the medical practitioners also remains a debatable issue. Despite the positives and the negatives in the overall market, analysts predict that the advanced remote patient monitoring systems will make an indelible mark by saving and transforming lives.

Introduction of Sustainable Medical Waste Reduction Programs by FDA and Top Players to Boost Reprocessed Medical Device Sales

The reprocessing of medical devices refers to a method of disinfecting, remanufacturing, testing, packaging, and labelling of expired, undamaged, and used medical devices. This is done for making these medical devices patient ready at a much lower cost. These devices are labelled and designed for a number of manufacturers and are made out of materials that are able to withstand repeated processing involving chemicals and manual brushing. The key aim of reprocessing medical devices, particularly within developing nations, is the reduction of costs for hospitals. 

Transparency Market Research (TMR), a market intelligence company, covers the key attributes related to the reprocessed medical devices market, such as the factors impacting market dynamics and the major steps taken by companies to propel its growth.

Q. What drivers and restraints are predicted to affect the dynamics of reprocessed medical devices market?

The rising pressure of lowering the medical waste generated will raise the demand for reprocessed medical devices. In addition, the growing adoption of reprocessed medical devices globally will also impact the market positively. The increasing pressure on hospitals and various other healthcare settings to operate under a fixed budget is also a major factor fuelling the development of the market. 

Furthermore, the rising preference for single-use reprocessed devices among of physicians, mainly as a patient safety measure owing to the reduced infection risks associated with the use of these devices, will further augment the development of the global reprocessed medical devices market. On the other hand, the absence of suitable regulatory guidelines and the growing apprehensiveness about the quality of reprocessed medical devices may impede the development of the market in the coming years.

Q. Is lowering the risks of improperly reprocessed medical devices a responsibility taken by the FDA?

Yes. The utilization of medical devices may result in the retention of tissue, blood, and other biological debris in some kinds of reusable medical devices. Further, this debris may lead in microbes surviving the sterilization process or disinfection, which may then result in heathcare- associated infections (HAIs). Hence, the reduction of risks of improperly reprocessed medical devices is a responsibility taken by a number of stakeholders. These include the healthcare facilities responsible for disinfecting or sterilizing, cleaning, manufacturers providing accurate reprocessing instructions that are likely to work and are user-friendly, and the FDA

In addition, the FDA has been activity engaged with a number of other federal agencies, local and state health departments, and professional societies, among others, for the enhanced understanding of the risk factors and causes of infectious agents. Accurate solutions are also being implemented by the FDA to minimize patient exposure. 

Q. Which type of reprocessed medical devices will gain popularity in the coming years and what steps have been taken by the prime players for encouraging the utilization of reprocessed medical devices? 

Cardiovascular reprocessed medical devices are poised to experience the highest growth in the coming years owing to the low cost of these devices and the rising focus on reducing the healthcare expenditure within hospitals.

The market for reprocessed medical devices includes a number of players involved in strategic alliances such as mergers and acquisitions and introduction of sustainable medical waste reduction programs. These players are also getting product approvals done for improving the supply and sales in the reprocessed medical devices market. For example, in June 2015, a subsidiary of Intalere, Inc., Intalere Choice, collaborated with HYGIA Health services for improving reprocessed medical devices’ supply, which will further positively impact the overall growth of this market. 

Global Prefilled Syringes Market Gains Significant Impetus from Continual Growth in Injectable Drugs Industry

Prefilled syringes have witnessed a significant rise in demand over the last decade. The ease of usage and the accuracy in the amount of drug to be injected offered by these syringes compared to conventionally packaged vials have increased their application across the world. Alongside, the continual growth in the injectable drugs industry has been positively influencing demand for prefilled syringes. Experts project this trend to continue to drive the global market for prefilled syringes in the coming years.

A publication by Transparency Market Research (TMR) states that the worldwide prefilled syringes market is likely to expand at a CAGR of 13.30% during the period from 2013 to 2019 and rise from US$2.1 billion in 2012 to US$4.9 billion by 2019.

Analysts at TMR answer important questions that participants in the global prefilled syringes market need to ask:

What are the major trends that are influencing the global prefilled syringes market?

The increasing trend of point-of-care administration of drugs is boosting the application of prefilled syringes significantly around the world. Technical advancements in these syringes have also impacted this market greatly in the recent past.

Apart from these, the usage of superior materials for the production of these syringes, together with cost containment by participants, is likely to emerge as a major growth driving trend in this market over the next few years. However, the advent of alternative methods is expected to influence this market negatively in the near future.

How the regional markets for prefilled syringes are likely to perform in the coming years?

The global prefilled syringes market is spread across Europe, Asia Pacific, North America, and the Rest of the World. Europe led the global market in 2015. However, North America, which emerged as the second-largest market that year, is likely to surpass Europe and acquire the leading position over the next few years. 

The rising preference for prefilled syringes over traditional vials and the presence of a large pool of leading manufacturers of injectables in this region are expected to boost the North America market for prefilled syringes significantly in the coming years. This regional market is estimated to expand at a CAGR of 15.0% during the period from 2013 to 2019. The prefilled syringes markets in Asia Pacific and the Rest of the World are also expected to rise at a healthy rate over the coming years.

What is the competitive structure of the global prefilled syringes market? What are the key strategies adopted by leading players?

The global prefilled syringes market demonstrates an oligopolistic nature of competition among participants. The top five market participants, namely, Becton, Dickinson & Co., Nipro Corp., Gerresheimer AG, Stevanato Group, and Schott AG together accounted for more than 85% of the overall revenue generated in the worldwide market in 2012.

Download Brochure for Professional & Technical Insights:

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1131

Forming strategic collaboration is the key trend among leading participants in this market. Recently, Becton, Dickinson and Co. entered into a partnership with Central Admixture Pharmacy Services Inc. (CAPS) in order to provide its customers a portfolio of frequently utilized prefilled anesthesia syringes of CAPS. Under this agreement, CAPS will provide a new service line of prefilled anesthesia syringes, which will be compatible with the BD Intelliport System.

Baxter International Inc., Bespak, Unilife Corp., and Ypsomed Holding AG are some of the other prominent players in the global prefilled syringes market.

Telehealth Initiatives to Improve Efficiency and Quality of Medical Tourism

Over the past two decades, plenty of telehealth applications have been successfully implemented. Applications such as the transfer of digital photos and patient records and the use of medical video endoscopes to monitor patients’ physical examination have demonstrated great results. For many players, the introduction of telehealth in the global medical tourism market has been a profitable strategy.

Telehealth improves the efficiency, customer service, and quality of medical tourism services via enhanced coordination of care between patients and care providers. According to Transparency Market Research (TMR), the global medical tourism market is expected to exhibit a 17.90% CAGR from 2013 to 2019. A rise in the elderly population and the rising number of uninsured people are some of the factors expected to propel the global medical tourism market. 

TMR experts answers a few questions with respect to the global medical tourism market:

Q. How would the implementation of telehealth drive medical tourism?

A. The use of telehealth in medical tourism can offer many benefits. Telehealth improves the quality and process of pre-operative and post-operative care. It also helps control the baseline data remotely. Anesthesiologists can remotely perform the physical assessment of respiratory systems via teleconsultation. 

Telehealth allows surgeons to manage follow-up care by connecting to primary care providers of patients. It also assures continuity in patient care by offering timely pre and post consultation. 

Leading players and the new entrants operating in the global medical tourism market have started adopting telehealth services for bridging the gap between patients and doctors. 

VoyagerMed, a New York-based medical care company, recently announced its plans to launch a telehealth initiative to connect patients from other countries to the U.S. physicians. The telehealth initiative is expected to allow patients to have real-time interaction with healthcare providers. 

Q. How will telehealth help players in global medical tourism market to serve patients in the urban and rural areas?

A. As telehealth is being implemented by many healthcare service providers, it will improve the access to care in urban and rural environments to a great extent. People travel abroad from their home country to avail advanced medical care facilities. Telehealth helps healthcare providers to reach people living in rural and urban areas and provide healthcare facilities. 

With telehealth, the medical tourism industry is being remade. For instance, millions of people travel to the U.S. to avail superior healthcare. Leading healthcare organizations in the U.S. have started using telehealth facilities to offer medical consultation to those who cannot afford to travel.

Q. What are the challenges faced by the hospitals using telehealth services?

Telehealth in medical tourism has certainly become a rising trend. However, healthcare organizations and hospitals using telehealth services need to consider a few challenges. Legal factors of every country can complicate the entire telehealth landscape. For instance, in the U.S., a telehealth doctor is transported to the patient’s country virtually. Thus, physicians, in order to offer their medical services, need to possess a valid license. 

As telehealth services are new, rules and regulations regarding inter-nation telehealth practices are not fully developed. This can hamper the growth of the global medical tourism market. 

For Technical Insights Avail PDF:

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=900

Over the past few years, there have been vast improvements in telehealth technologies. Although there are a few technical, regulatory, legal, and organizational obstacles, they are manageable. Going forward, telehealth is expected to play a leading role in shaping the global medical tourism market.  

Wearable Medical Technology Becomes Less Gimmicky and Readies for Serious Implementations

The proliferation of wearable technologies into a field based on necessity, i.e. the healthcare industry, has been a long awaited move. Current variants of commercially available – and financially viable for the majority – wearable tech includes fitness tracking wristwatches and the likes. The healthcare industry has bigger plans for wearables and is already on the way to help people from all walks of life gain functional and increasingly useful tech that can help them live better. The modern wearable medical technologies are aimed at helping the elderly, the athletes, the disabled, and the chronically sick to perform daily tasks while not getting in their way.

Industry experts from Transparency Market Research have evaluated the global wearable medical technologies market to quantify its imminent future progress rate. To explain the analysis, the analysts have answered three question crucial to grasping the market dynamics.

What are Some of the more Commercialized Medical Wearables?

The most common use of medical wearable comes in various forms of wrist bands or watches. We have, for instance the wristbands integrated with Near Field Communication that allow a nearby scanning device to tag the band and receive an individual’s medical data. Other wrist band types may allow a patient to check their pulse, their sleep patterns, a fall or an accident, and even sleepwalking. The bands can alert the user to take their medicine on time, or alert medical personnel, hospitals, and close ones of any incident that may have occurred.

In fact, most of the wearable medical devices are a result of the convergence of conventional medical devices with portable consumer electronics. This will give us a much clearer perspective on how the global wearable medical technologies market is expected to progress in the near future.

What Other Aspects of Modern Electronics are Incorporated in Medical Wearables?

Essentially, all technologies in consumer electronics can be utilized to improve the devices in the global wearable medical technologies market. For instance, the integration of the Internet of Things (IoT) can be extremely helpful in creating a secure connected environment for a patient within a small space. The connected devices can help the patient perform daily functions without human assistance, order for prescription drugs and pay for them online, keep a record of their health, and most importantly, allow medical personnel to remotely monitor them.

Are There Any Immediate Concerns to the Global Wearable Medical Technologies Market?

There are quite a few concerns, the most pressing of which is user safety and measurement accuracy. Device safety standards and testing may be, however rarely, lacking in a definitive set of guidelines to dictate the terms of use. Most policies, such as the U.K., Medicines and Healthcare Products Regulatory Agency’s policy, is to establish the responsibility of safety directly on the manufacturer. The agency has clearly stated in its guidelines that the manufacturers need to use a proper set of controls on the device to ensure the most safe user experience.

For Technical Insights Visit: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1651

As for accuracy, it’s a two way street. Common lifestyle and fitness devices need a certain set of data inputs that need to be accurately fed to receive the right results. One of the biggest problems most users face is that these devices can be inaccurate at times. And the repercussions of a wrong reading can be increasingly severe when performed by medical wearables that are used by, say, cancer patients or the chronically ill. 

These issues must be addressed properly in order to ensure a smooth growth trajectory for the global wearable medical technologies market.

Demand for Noninvasive Prenatal Testing (NIPT) Propelled by Rising Incidence of Genetic Disorders, Surge in R&D

Recent advances in bioinformatics and genomic sequencing have resulted in the development of various noninvasive prenatal testing (NIPT) methods. NIPT is recommended by gynecologists to detect the risk an unborn child may present for various genetic disorders, including Down syndrome. This screening method has been gaining popularity with the commonness of fetal chromosomal aneuploidies and the dangers of high-risk pregnancies. 

The global NIPT market, according to industry experts, is forecast to expand at a 17.5% CAGR from 2014 to 2022, rising from a value of US$0.5 bn in 2013 to US$2.3 bn by 2022.

Q. What is the leading factor fueling the demand for noninvasive prenatal testing?

A. The rising incidence of several fetal chromosomal aneuploidies, such as Edwards’ syndrome, Down syndrome, Turner syndrome, and Patau syndrome, has significantly driven the need for noninvasive prenatal testing. 

According to the World Health Organization, the incidence of Down Syndrome is estimated to be between 1/1,000 and 1/1,100 live births worldwide. It has been estimated that around 3,000 to 5,000 children are born with Down syndrome each year and around 250,000 families in the U.S. are affected by this chromosomal disorder. Edwards’ syndrome, also called the trisomy 18 syndrome, is the second most common autosomal trisomy syndrome after Down syndrome. The National Institutes of Health (NIH) states that this disorder has an estimated live born prevalence of 1 in every 6,000 to 1 in every 8,000 births. Patau syndrome, on the other hand, is known to occur in around 1/10,000 to 1/16,000 live births each year, the NIH finds. 

Each of these chromosomal disorders results in severe developmental and intellectual disabilities in the child, in addition to various physical problems. As a result, the prenatal diagnosis of these disorders via NIPT has become a growing need in cases of high-risk pregnancies.

Q. How far has research come in examining the efficacy and accuracy of NIPT?

A. Today, there are an increasing number of companies that use different analytic methods for noninvasive prenatal testing, also called noninvasive prenatal diagnosis or cell-free DNA-based noninvasive prenatal screening. Compared to previous NIPT methods, modern screening techniques reportedly present a higher detection rate for trisomy 18 (96.85), trisomy 21 (99.0%), and trisomy 13 (92.1%), according to a study published in the New England Journal of Medicine. The study, titled ‘Accurate Description of DNA-based Noninvasive Prenatal Screening,’ was conducted in 2015 by a team of researchers from the University of Hong Kong, the Chinese University of Hong Kong, and the Baylor College of Medicine, Texas. 

Browse Research Release:

http://www.transparencymarketresearch.com/pressrelease/global-noninvasive-prenatal-diagnostics-market.htm

The study found that more and more companies in the NIPT market are now expanding their screening methods to include the detection of increasingly rare chromosomal abnormalities. The study compared the efficacy of six laboratories, namely Ariosa, Illumina, Integrated Genetics, Sequenom, Natera, and BGI, in terms of detecting false positives and false negatives. The study found that BGI’s NIPT test performed better than all the others examined. It also described that there are several intrinsic biologic factors such as confined placental mosaicism, somatic mosaicism, and maternal copy-number imbalance that are responsible for false negative and false positive results of NIPT.

Need for Operational Efficiency and Improved Healthcare Services Drives Medical Automation Market

Automation can be highly advantageous for the pharmaceuticals industry. Automation brings in an operational advantage and has the potential to redefine the future of the healthcare industry. The advent of accurate, faster, and easy-to-use medical devices is expected to be a real game changer for the medical automation market.

One of the major reasons why medical automation has become essential in the medical industry is the shortage of nurses. As per an article published in Health Affairs, by 2025, it is expected that the healthcare industry in the U.S. will face a shortage of about 260,000 nurses. A similar scenario is expected in other developed countries where the workforce is rapidly aging. A rise in the aging population will require more care and more staffing levels, which the healthcare industry will not be able to provide due to a shortage of staff. Thus, with fewer humans available to carry out tasks in the healthcare industry, many pharmaceutical and healthcare companies are focusing on automation. The global medical automation market is growing, states a research report by Transparency Market Research (TMR). 

In this blog post, TMR answers three critical questions about the medical automation market:

Q. What is driving the healthcare industry towards medical automation?

An average hospital’s financial statement will reveal that around 50-60% of its expenses are on salaries and benefits. Medical automation will reduce the need for hiring more staff and thus, save expenses, while doing the tasks more efficiently and quickly. Automation will soon become essential and not just a luxury as there will be a lack of care providers who can continuously check on the patients and monitor them. This need will drive the medical automation market. 

Moreover, medical automation has several advantages, such as, improving quality and consistency, reduced paper waste, and data driven insights. These benefits are expected to boost the medical automation industry. 

Technical Insights: http://www.transparencymarketresearch.com/medical-automation-market.html

Q. How is medical automation improving productivity and reducing dependence on IT?

Many of the healthcare companies depend extensively on the IT department for addressing their issues and needs in a timely manner. However, it is not always possible for the IT department to have the manpower or the solution to every problem. For instance, Envision Healthcare enlisted ServiceNow for medical automation services. This has helped them reduce dependence on their IT department and cut IT lead times. Electronic approval processes, less paperwork, and automation of the workflow have all helped in the streamlining of the department and reduced operational costs. 

Q. What are the recent developments in the medical automation industry? 

GE Healthcare and Accenture have announced the extension of their partnership to bring to table a leading analytics technology that can help improve medical claims processing, which is critical for the healthcare industry, especially in the U.S. The two companies are expected to combine their capabilities and drive the financial performance of healthcare organizations. The analytics technology is expected to provide healthcare organizations with actionable insights that can reduce claims denials. 

With such new technologies being developed rapidly and integrated into the day-to-day activities, health care organizations will have more data sources. 

Accuracy in Real-time Imaging Offered by Advanced 3D/4D Visualization Systems Drives Market Growth

The advanced visualization technology aids a plethora of significant applications in various clinical departments including oncology, cardiology, radiology, neurology, gynecology, obstetrics, and dentistry. In recent times, the deployment of advanced 3D/4D visualization systems has witnessed a remarkable upsurge in multimodal imaging solutions. The accuracy these systems provide in real-time imaging has increased their demand in clinical diagnosis procedures and the trend is likely to report steady growth in the near future.

The significance of advanced visualization systems in the interpretational workflow of imaging systems, such as computed tomography (CT) and magnetic resonance imaging (MRI), is also boosting their demand extensively and is projected to provide a substantial thrust to the market over the next few years.

A recent publication by Transparency Market Research (TMR) on the global advanced 3D/4D visualization systems market states that the market will rise from US$1.8 bn in 2015 to a value of US$3.2 bn by the end of 2024. Analysts expect the market to register a CAGR of 6.40% during the period from 2016 to 2024.

In this blog post, TMR experts answer the important questions regarding the worldwide advanced (3D/4D) visualization systems market:

What are the factors that are influencing the growth of this market across the world?

The worldwide market for advanced 3D/4D visualization systems is substantially propelled by the global rise in the number of medical procedures. The growing demand for the digitization of data related to patients and the technical advancements in medical imaging are also influencing the growth of this market positively.

On the other hand, the high cost associated with equipment used in advanced visualization systems and their deployment and maintenance is having a negative impact on the global advanced 3D/4D visualization systems market. However, the development of novel software is projected to aid this market significantly in the coming years. 

How the major regional markets for advanced 3D/4D visualization systems have been performing over the years?

North America has emerged as the leading regional market for advanced 3D/4D visualization systems across the world. The presence of a highly developed medical and healthcare infrastructure, strong economic condition, easy access to advanced technologies, and the increased awareness among patients regarding healthcare have boosted this market in North America over the past few years.

The markets for advanced (3D/4D) visualization systems in Europe and Asia Pacific are also exhibiting robust growth. The increased expenditure on healthcare in Europe is propelling the European market while the large population is the key factor, driving the Asia Pacific market.

On the flip side, the market in the Middle East and Africa is likely to witness some sluggishness in the coming years as the high cost of deployment and maintenance of these systems is likely to hinder their adoption.

Browse Research Release:

http://www.transparencymarketresearch.com/pressrelease/advanced-3d-4d-visualization-systems.htm

What are the crucial strategies adopted by leading market participants for the expansion of their businesses?

Major players are aggressively focusing on including technically-advanced products in their portfolios. Partnerships and mergers and acquisitions are also frequently adopted strategies by leading participants in the global advanced 3D/4D visualization systems market.

Most recently, GE Healthcare collaborated with TCS to develop efficient solutions on the GE Health Cloud, which connects over 500,000 of GE’s advanced imaging systems. TCS will be ensuring the quality control and regulatory compliance of the GE Health Cloud and its solutions. Centricity Cloud Advanced Visualization, the latest radiology app on the GE Health Cloud, will also be managed by TCS.

U.S. Medical Waste Management Market: Newer Initiatives will Improve Pathway towards Healthy and Safe Disposal of Medical Waste

As per the Environmental Protection Agency (EPA), all types of waste materials generated by healthcare facilities such as clinics, hospitals, dental practices, physician’s offices, veterinary clinics or hospitals, and medical research laboratories or facilities come under medical waste. Medical care plays a vital role in the protection of health, well-being, and life of human beings. However, these healthcare activities generate waste which may prove to be very detrimental resulting in infections and diseases in human beings. These risks are being overcome by establishing safety and environmental regulations for the storage and treatment of medical waste particularly within the U.S. This has resulted in the exponential rise of the medical waste management market in the U.S.

Transparency Market Research (TMR), a market intelligence company, provides a detailed overview of the medical waste management market in the U.S. by providing answers to some of the most relevant questions.

Q. What are the recent steps being taken by the government and non-government agencies in the U.S. for the disposal of medical waste?

As per the State University of New York and The Levin Institute, medical waste has emerged as the third-largest source of waste in the U.S. and hospitals have a total contribution of more than 2 mn tons of medical waste yearly within the U.S. 

The Drug Enforcement Administration (DEA) has been actively involved in the regulation of medical waste within the U.S. since past many years. A number of plans have been made for proper segregation techniques of medical waste and waste audits have been started to reduce the overall medical waste production in the U.S. In addition, transportation is also being monitored in order to keep a check on the proper transportation of the waste to the facility of disposal. Furthermore, policies are being implemented to gauge the types and volumes of medical waste that are being produced and steps have been implemented to minimize this waste. 

Q. What are the key factors propelling and inhibiting the growth of the U.S. medical waste management market?

The increasing aging population in the U.S. is a major factor fuelling the growth of the medical waste management market in the U.S. This is because of the fact that the aging population is more prone to infections, injuries, and diseases. This results in more hospital visits, thus contributing to the medical waste production. In addition, the expanding pharmaceutical and healthcare industries are also greatly contributing to the growth of the market. Furthermore, a number of technological advancements in the market have resulted in new methods of waste disposal, hence augmenting the growth of the market in the U.S. 

On the other hand, the increasing focus towards small quantity waste generators and the soaring initial capital investment involved in waste management are the major factors that may restrain the growth of the market.

Browse Regional PR:

http://www.transparencymarketresearch.com/pressrelease/us-medical-waste-management-market.htm

Q. Which are the key medical waste disposal companies in the U.S? What are their contributions to the market?

The key companies operating in the waste management market in the U.S. are Waste Management, Inc., Stericycle, and XMED Disposal, Inc., among others. Amongst these, Waste Management, Inc. is one of the biggest medical waste management companies in North America and develops new waste solutions. This company serves over 20 mn customers within Canada and the U.S. On the other hand, Stericylce specializes in chemotherapeutic waste disposal in South America and North America. 

High Occurrence of Periodontal Diseases Drives Dental Bone Graft Substitutes and other Biomaterials Market

Dental hygiene has become an important part of everyday discussions about cosmetics and aesthetics amongst the young and the old. In recent years, maintaining gums and teeth in good health has become especially popular, with consumers being constantly influenced with strong advertisements by toothpaste companies and other oral hygiene players. Despite the ongoing research, free dental checkups, and high awareness about oral hygiene, many fall prey to the complications of periodontal (gum) disease. A study published by Centers for Disease Control and Prevention (CDC) states that about 47% of adult U.S. population, which is above 30 years of age, have a mild, moderate, or severe form of periodontitis. This statement is enough to support the fact that global dental bone graft substitutes and biomaterials market is estimated to rise at a CAGR of 10.6% from 2014 to 2020. 

Q. Which segment will drive the overall market?

A. The materials used for making dental bone graft substitutes and other biomaterials are natural, ceramics, polymers, and composites. Out of all these, the natural materials segment ambled ahead of others in 2013. Its sub-segments allografts and xenografts also contributed significantly to the growth of this. Analysts predict that the xenografts sub-segment will expand at a CAGR of 11.10% during the forecast period. The growth of this segment will be attributable to the trend of collecting bone tissues of bovine animals instead of humans. This trend will be complemented by the rising acceptance of grafts from animals in surgical procedures.

Q. What will drive the global dental bone graft substitutes and other biomaterials market?

A. The increasing number of edentulous patients and a high incidence of periodontal diseases are expected to be primary growth drivers the overall market. Furthermore, the improvement in the quality of life offered by dental implants is also expected to propel this market in the near future. The growing trend of smile correction at affordable pricing, exceptionally high rate of success for implants, and faster recovery time are all anticipated to boost this market in the coming years.

Browse Regional PR: 

http://www.transparencymarketresearch.com/pressrelease/dental-bone-graft-substitutes-biomaterials-market.htm

Q. How will the rise of dental tourism change competitive landscape?

A. Until recently, North America and Europe jointly held a share of 70% in the overall market. Their dominance was supported by the presence of big players in the regions such as Institut Straumann AG and DENTSPLY International. However, with the rise of dental tourism in Asia Pacific, the region is set to surpass this share in the forecast period changing the competitive landscape drastically. APAC will also benefit from the growing number of geriatrics in the emerging economies of this region.

The only restraining factor in the overall market is FDA’s disapproval in the U.S. for the use bone grafts on patients below the age of 18 years as it could cause serious injuries. This is expected to hamper the growth of the market in the U.S.